
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Eumycetoma: pathogenesis, current treatments, and the search for new drugs - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5343268AF3FB430543260044579084.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="springeropen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364754/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Applied Microbiology and Biotechnology">
<meta name="citation_title" content="Eumycetoma: pathogenesis, current treatments, and the search for new drugs">
<meta name="citation_author" content="Dounia El Yachioui">
<meta name="citation_author_institution" content="Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015 GD The Netherlands">
<meta name="citation_author" content="Tim Baltussen">
<meta name="citation_author_institution" content="Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015 GD The Netherlands">
<meta name="citation_author" content="Wendy W J van de Sande">
<meta name="citation_author_institution" content="Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015 GD The Netherlands">
<meta name="citation_publication_date" content="2025 Aug 19">
<meta name="citation_volume" content="109">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="187">
<meta name="citation_doi" content="10.1007/s00253-025-13580-5">
<meta name="citation_pmid" content="40830304">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364754/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364754/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364754/pdf/253_2025_Article_13580.pdf">
<meta name="description" content="Eumycetoma is a neglected tropical disease which can be caused by 69 different fungal species. In 2024, eumycetoma was listed as a high priority fungal infection on the fungal priority list of the World Health Organization. Eumycetoma is ...">
<meta name="og:title" content="Eumycetoma: pathogenesis, current treatments, and the search for new drugs">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Eumycetoma is a neglected tropical disease which can be caused by 69 different fungal species. In 2024, eumycetoma was listed as a high priority fungal infection on the fungal priority list of the World Health Organization. Eumycetoma is ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364754/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12364754">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1007/s00253-025-13580-5"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/253_2025_Article_13580.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12364754%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12364754/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12364754/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364754/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-springeropen.png" alt="Springer logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Springer" title="Link to Springer" shape="default" href="https://doi.org/10.1007/s00253-025-13580-5" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Appl Microbiol Biotechnol</button></div>. 2025 Aug 19;109(1):187. doi: <a href="https://doi.org/10.1007/s00253-025-13580-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1007/s00253-025-13580-5</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Appl%20Microbiol%20Biotechnol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Appl%20Microbiol%20Biotechnol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Appl%20Microbiol%20Biotechnol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Appl%20Microbiol%20Biotechnol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Eumycetoma: pathogenesis, current treatments, and the search for new drugs</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yachioui%20DE%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Dounia El Yachioui</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Dounia El Yachioui</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015 GD The Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Yachioui%20DE%22%5BAuthor%5D" class="usa-link"><span class="name western">Dounia El Yachioui</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baltussen%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Tim Baltussen</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Tim Baltussen</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015 GD The Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Baltussen%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tim Baltussen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20de%20Sande%20WWJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Wendy W J van de Sande</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Wendy W J van de Sande</span></h3>
<div class="p">
<sup>1</sup>Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015 GD The Netherlands </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22van%20de%20Sande%20WWJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Wendy W J van de Sande</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Dr. Molewaterplein 40, Rotterdam, 3015 GD The Netherlands </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 3; Revised 2025 Aug 7; Accepted 2025 Aug 8; Issue date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by-nc-nd/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc-nd/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12364754  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40830304/" class="usa-link">40830304</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Abstract</h3>
<p id="Par1">Eumycetoma is a neglected tropical disease which can be caused by 69 different fungal species. In 2024, eumycetoma was listed as a high priority fungal infection on the fungal priority list of the World Health Organization. Eumycetoma is characterized by chronic subcutaneous swelling, the formation of grains, and progressive tissue destruction. If left untreated, it can lead to severe complications such as bone destruction and permanent disability. Current antifungal treatments, such as itraconazole and terbinafine, are lengthy and often ineffective without surgical intervention. The search for novel treatments is challenging due to limited interest and return of investment. Drug repurposing has emerged as a promising strategy for discovering new effective therapies against eumycetoma. Additionally, the MycetOS initiative focuses on developing novel antifungal compounds that are tested in vitro and in vivo.</p></section><section id="sec2"><h3 class="pmc_sec_title">Key points</h3>
<ul class="list" style="list-style-type:disc">
<li><p id="Par3">
<em>Pathogenesis involves the formation of grains to protect the fungus</em>
</p></li>
<li><p id="Par4">
<em>New treatments are needed for eumycetoma to reduce recurrence and amputation rates</em>
</p></li>
<li><p id="Par5">
<em>Drug repurposing and MycetOS are key strategies for developing new treatments</em>
</p></li>
</ul></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Mycetoma, Drug discovery, Fungal infectious disease, MycetOS</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par6">Mycetoma is a neglected tropical disease (NTD), recognized in 2016 by the World Health Organization (WHO) (WHO <a href="#CR61" class="usa-link" aria-describedby="CR61">2016</a>). The disease manifests as subcutaneous tumor-like swellings. In these swellings sinuses can be formed which discharge fungal granules called grains (Fig. <a href="#Fig1" class="usa-link">1</a>A) (Zijlstra et al. <a href="#CR64" class="usa-link" aria-describedby="CR64">2016</a>). Lesions differ significantly in size, ranging from small nodes less than 5 cm to a large tumor-like growth &gt; 10 cm (Siddig et al. <a href="#CR47" class="usa-link" aria-describedby="CR47">2023</a>).
</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364754_253_2025_13580_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9196/12364754/ffce83ace098/253_2025_13580_Fig1_HTML.jpg" loading="lazy" id="MO1" height="238" width="676" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>A</strong>): A person affected by Mycetoma, showing foot lesions and mobility impairment (CDC <a href="#CR9" class="usa-link" aria-describedby="CR9">2024b</a>). <strong>B</strong>) Black grain inside subcutaneous tissue, with 1 cm ruler beneath it (CDC <a href="#CR8" class="usa-link" aria-describedby="CR8">2024a</a>) <strong>C</strong>) hematoxylin–eosin staining of eumycetoma grain</p></figcaption></figure><p id="Par7">Mycetoma is classified into two groups based on the causative agent: actinomycetoma, caused by filamentous, aerobic bacteria, and eumycetoma, caused by filamentous fungi. Together, there are over 80 microorganisms known to cause mycetoma, 69 of these are fungi (van de Sande et al. <a href="#CR57" class="usa-link" aria-describedby="CR57">2018</a>; van de Sande and Fahal <a href="#CR54" class="usa-link" aria-describedby="CR54">2024</a>). In this review we will focus only on eumycetoma. We will specifically focus on pathogenesis, treatment and the ongoing efforts to improve the treatment of eumycetoma.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Pathogenesis</h2>
<p id="Par8">While the exact origin of the disease is not fully known, the current hypothesis is that the pathogen enters the body through wounds or abrasions in the skin (van de Sande et al. <a href="#CR56" class="usa-link" aria-describedby="CR56">2014</a>). Farmers and other agricultural laborers are most affected due to direct contact with contaminated soil, thorns, or animal dung (Fahal and Bakhiet <a href="#CR18" class="usa-link" aria-describedby="CR18">2023</a>). Once inside the body, the causative agents form grains which are often 1–2 mm in diameter to enhance their own survival within the host (Fig. <a href="#Fig1" class="usa-link">1</a>B) (van de Sande <a href="#CR53" class="usa-link" aria-describedby="CR53">2021</a>). Within these grains, the fungal hyphae are found. Depending on the species, these grains can be embedded in a protective cement-like matrix (Fig. <a href="#Fig1" class="usa-link">1</a>C).</p>
<p id="Par9">Eumycetoma has been identified in 102 countries, but the prevalence of reported cases varies significantly across regions. Eumycetoma is endemic to countries with a (sub)tropical climate, primarily within the mycetoma belt, located between 15°S and 30°N latitude. The highest incidence of cases is reported in Sudan, Senegal and India (Emery and Denning <a href="#CR17" class="usa-link" aria-describedby="CR17">2020</a>). The strongest predictors of mycetoma occurrence are aridity, proximity to water, low soil calcium and sodium concentrations, and the distribution of various thorny plants (Hassan et al. <a href="#CR25" class="usa-link" aria-describedby="CR25">2021</a>). The most common causative agents of eumycetoma are <em>Madurella mycetomatis</em> (n = 10,556 reported eumycetoma cases), <em>Falciformispora senegalensis</em> (n = 435), <em>Trematosphaeria grisea</em> (n = 173)<em>, Scedosporium boydii</em> (n = 120) and <em>Medicopsis romeroi</em> (n = 78) (van de Sande and Fahal <a href="#CR54" class="usa-link" aria-describedby="CR54">2024</a>). <em>M. mycetomatis</em> was reported world-wide, while <em>F. senegalensis</em> is primarily found in West-Africa (Siddig et al. <a href="#CR47" class="usa-link" aria-describedby="CR47">2023</a>). In North America, <em>Scedosporium</em> spp. are the most common causative agents of eumycetoma, while in Latin America, the Caribbean, and South America, <em>Nigrograna mackinnonii</em> is the most prevalent (Ahmed et al. <a href="#CR4" class="usa-link" aria-describedby="CR4">2018</a>).</p>
<p id="Par10">The time required to form a lesion varies, depending on the causative agent and patient, ranging from a few weeks to several years (Nenoff et al. <a href="#CR42" class="usa-link" aria-describedby="CR42">2015</a>). The most common site of lesions is in the foot (76%) and, less frequently, in the hand (8%) (Fahal et al. <a href="#CR20" class="usa-link" aria-describedby="CR20">2015</a>). In the initial stages of eumycetoma, the lesions remain small (&lt; 5 cm) and are often painless (El-Amin et al. <a href="#CR15" class="usa-link" aria-describedby="CR15">2024</a>). In the later stages of disease progression (&gt; 10 cm), where the lesion has formed sinuses and bone destruction is present, patients are more likely to experience pain (El-Amin et al. <a href="#CR15" class="usa-link" aria-describedby="CR15">2024</a>). In other cases where the patient obtains a secondary bacterial infection, pain is reported in 18–20% of patients (Fahal et al. <a href="#CR21" class="usa-link" aria-describedby="CR21">2018</a>). The swelling is usually firm, round and mobile, but there have been cases where it is soft and lobulated (Fahal et al. <a href="#CR21" class="usa-link" aria-describedby="CR21">2018</a>). Over time, the swelling increases and stretches the skin (van de Sande and Fahal <a href="#CR54" class="usa-link" aria-describedby="CR54">2024</a>). Pus and grains are discharged through the sinus tracts. These sinuses may close after discharge, while new ones can form (Fahal et al. <a href="#CR21" class="usa-link" aria-describedby="CR21">2018</a>). The disease spreads further through the bloodstream and the lymphatic system (Zijlstra et al. <a href="#CR64" class="usa-link" aria-describedby="CR64">2016</a>). As the infection progresses, the fungus penetrates the periosteum and cortex of the bone, creating small cavities (Abd El Bagi <a href="#CR1" class="usa-link" aria-describedby="CR1">2003</a>). If left untreated, the fungus can spread deeper into the bone or towards other bones (Abd El Bagi <a href="#CR1" class="usa-link" aria-describedby="CR1">2003</a>). This could lead to severe disfiguration, disability and amputation, and could cause economic and medical burdens to the community (Ahmed et al. <a href="#CR3" class="usa-link" aria-describedby="CR3">2004</a>; Singh et al. <a href="#CR48" class="usa-link" aria-describedby="CR48">2020</a>).</p></section><section id="Sec3"><h2 class="pmc_sec_title">Grain formation</h2>
<p id="Par11">One of the most characteristic features of mycetoma is the formation of grains by the causative agent. Most fungi produce black grains, however, there have been instances where white, yellow and green grains have been found after fungal infection (van de Sande and Fahal <a href="#CR54" class="usa-link" aria-describedby="CR54">2024</a>). The black color is caused by melanin, which is synthesized through the 1,8-Dihydroxynaphthalene- (DHN), 3,4-dihydroxyphenylalanine- (DOPA), and pyomelanin pathways and is attached to extracellular proteins (Lim et al. <a href="#CR33" class="usa-link" aria-describedby="CR33">2022a</a>; van de Sande et al. <a href="#CR55" class="usa-link" aria-describedby="CR55">2007</a>). Inside the grain, the hyphae of the fungus are embedded into a cement material. The proteins and DNA present in the cement material originate mainly from the host (99.3%). Only a small fraction (0.069%) is originating from the pathogen (Sheehan et al. <a href="#CR46" class="usa-link" aria-describedby="CR46">2020</a>; van de Sande and Fahal <a href="#CR54" class="usa-link" aria-describedby="CR54">2024</a>). In humans, it was found that zinc, copper and calcium levels were significantly higher in tissues infected with <em>M. mycetomatis</em> (Ibrahim et al. <a href="#CR27" class="usa-link" aria-describedby="CR27">2013</a>).</p>
<p id="Par12">The process of grain formation has been studied in the larvae of the greater wax moth <em>Galleria mellonella.</em> In this invertebrate, grains are formed which are similar to those observed in human patients and mycetoma infected mouse models (Kloezen et al. <a href="#CR28" class="usa-link" aria-describedby="CR28">2015</a>). Additionally, <em>G. mellonella</em> larvae possess an innate immune system that shares similarities with the human innate immune system (Browne et al. <a href="#CR6" class="usa-link" aria-describedby="CR6">2013</a>). So far, invertebrate models have only been developed for <em>M. mycetomatis</em> and <em>F. senegalensis</em> (Kloezen et al. <a href="#CR28" class="usa-link" aria-describedby="CR28">2015</a>; Ma et al. <a href="#CR36" class="usa-link" aria-describedby="CR36">2023</a>). In <em>G. mellonella, M. mycetomatis</em> grain formation can be divided into four developmental stages over 7 days (Kloezen et al. <a href="#CR28" class="usa-link" aria-describedby="CR28">2015</a>). Already at 4 h post-infection, the early signs of grain formation are present. In this stadium hyphae are clustered and cement material begins to form. By 24 h post infection, the cement material is fully formed, with only a few host cells present within the grains. After 72 h, no host cells are present within the cement material anymore, and in the final stage, immune cells surround the grain (Kloezen et al. <a href="#CR28" class="usa-link" aria-describedby="CR28">2015</a>). Grain formation seems to be slower in <em>F. senegalensis</em> infected <em>G. mellonella</em> larvae. At 4 h post-infection, only loose hyphae are observed. By 24 h, early signs of grain formation are seen, but without cement material or melanization. At 72 h, cement material is formed, along with capsule formation and by day 7, the grain is fully mature (Ma et al. <a href="#CR36" class="usa-link" aria-describedby="CR36">2023</a>).</p>
<p id="Par13">Based on the transcriptomic and proteomic analyses performed on different time points during <em>M. mycetomatis</em> grain formation in <em>G. mellonella,</em> a model for grain development was formed (Abugessaisa et al. <a href="#CR2" class="usa-link" aria-describedby="CR2">2022</a>; Sheehan et al. <a href="#CR46" class="usa-link" aria-describedby="CR46">2020</a>)<em>.</em> In this model grain formation was divided into 4 stages. In the first stage, the pathogen enters the body and will be recognized by the host via pattern recognition receptors (Fig. <a href="#Fig2" class="usa-link">2</a>A). The fungus responds by increasing vesicles transport and producing materials to generate an extracellular matrix through the cell wall. The fungus uses adhesion proteins to attach itself to the host cells (Fig. <a href="#Fig2" class="usa-link">2</a>B). Hemocytes will cluster around the fungus and cross-link to each other. The fungus secretes zincophores and siderophores to retrieve zinc and iron for survival. At this point, degranulation of the hemocytes happens, which causes high reactive oxygen species production and discharge of antimicrobial peptides (Fig. <a href="#Fig2" class="usa-link">2</a>C). As a protective mechanism, the fungus produces melanin, which forms a capsule around the grain (Fig. <a href="#Fig2" class="usa-link">2</a>C). It was seen in the <em>G. mellonella</em> model that no hemocytes were found inside the grain anymore, proposing that the fungus has killed the hemocytes (Fig. <a href="#Fig2" class="usa-link">2</a>D).</p>
<figure class="fig xbox font-sm" id="Fig2"><h3 class="obj_head">Fig. 2.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364754_253_2025_13580_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9196/12364754/1b3db907e1b5/253_2025_13580_Fig2_HTML.jpg" loading="lazy" id="MO2" height="215" width="678" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Grain formation over time. <strong>A</strong> Fungal hyphae are recognized by Pattern Recognition Receptors as pathogens. <strong>B</strong> Immune cells will aggregate around the hyphae, and host cell will cross-link and bind to the fungal cells. <strong>C</strong> Reactive oxygen species are produced by granulated cells. The fungus produces melanin and trehalose and forms a capsule. <strong>D</strong> The fungus fully breaks down the host cells and creates cement material. Figure based on reference (van de Sande and Fahal <a href="#CR54" class="usa-link" aria-describedby="CR54">2024</a>), made with Biorender</p></figcaption></figure><section id="Sec4"><h3 class="pmc_sec_title">Diagnosis</h3>
<p id="Par14">Currently, diagnosis relies on clinical presentation and identification of the causative agent. Imaging techniques such as X-rays, ultrasound, magnetic resonance and computer tomography are used to assess the extent of the lesions and aid in the clinical management. To identify the causative agent, tissue samples containing the grains are collected via surgical biopsy or fine needle aspiration. Culturing the grains is the gold standard to identify the causative agent. However, this method is time-consuming, and its accuracy is limited, as identification relies on colony morphology (Siddig et al. <a href="#CR47" class="usa-link" aria-describedby="CR47">2023</a>). Histopathology, alone has a specificity of 42.8% compared to molecular identification (Siddig et al. <a href="#CR47" class="usa-link" aria-describedby="CR47">2023</a>). This is due to the black grains being misclassified as <em>M. mycetomatis.</em> Molecular identification with polymerase chain reaction (PCR) is the most specific method to determine the causative agent, but due to high cost and lack of standardized techniques it is not used in the endemic areas (Siddig et al. <a href="#CR47" class="usa-link" aria-describedby="CR47">2023</a>). However, an effort is made to implement PCRs in endemic areas by several groups.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Treatment</h3>
<section id="Sec6"><h4 class="pmc_sec_title">Current treatments</h4>
<p id="Par15">Actinomycetoma can often be successfully treated with a combination of antibiotics, such as sulfonamides, amoxicillin and tetracyclines, without the need for surgery (Welsh et al. <a href="#CR60" class="usa-link" aria-describedby="CR60">2013</a>). Although cure rates for actinomycetoma can be as high as 90%, treatment remains challenging due to the prolonged duration of therapy, the emergence of antibiotic resistance, and the high cost of newer drugs, which limits accessibility for many patients (Cárdenas-de la Garza et al. <a href="#CR7" class="usa-link" aria-describedby="CR7">2020</a>).</p>
<p id="Par16">In contrast, the treatment of eumycetoma is even more challenging, often requiring long-term antifungal therapy combined with surgery (Fig. <a href="#Fig3" class="usa-link">3</a>). Treatment outcomes are often less than ideal, with low cure rates, a high chance of recurrence, and, in severe cases, the possibility of amputation (38.5%) (Clark et al. <a href="#CR10" class="usa-link" aria-describedby="CR10">2024</a>). These challenges are mainly due to limited available resources of affected populations. Treatment success also depends on factors such as the causative agent, disease stage, and the extent of the lesions. While early-stage nodules can often be treated effectively without surgery, advanced stages are significantly more difficult to treat (Elkheir et al. <a href="#CR16" class="usa-link" aria-describedby="CR16">2020</a>).</p>
<figure class="fig xbox font-sm" id="Fig3"><h5 class="obj_head">Fig. 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364754_253_2025_13580_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9196/12364754/45643afe883e/253_2025_13580_Fig3_HTML.jpg" loading="lazy" id="MO3" height="281" width="678" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Treatment of eumycetoma: 6 months of itraconazole therapy, followed by surgery, and an additional 6 months of itraconazole to minimize recurrence risk. Each grey block represents 1 month, the red block represents the surgical intervention. Figure made with Biorender</p></figcaption></figure><section id="FPar1"><h5 class="pmc_sec_title">Itraconazole</h5>
<p id="Par17">Currently, itraconazole is the first-line antifungal treatment in endemic regions (Fig. <a href="#Fig3" class="usa-link">3</a>). The standard regimen consists of 400 mg of itraconazole daily for 6 months, followed by surgical intervention to remove the lesion. This pre-surgery treatment is to facilitate lesion encapsulation and localization, thereby reducing the extent of surgical intervention and minimizing the risk of recurrence(Fahal et al. <a href="#CR19" class="usa-link" aria-describedby="CR19">2011</a>). After surgery, the patient continues itraconazole therapy for at least an additional 6 months. Itraconazole inhibits the cytochrome P450-dependent enzyme lanosterol 14-alpha-demethylase (CYP51A), preventing the synthesis of ergosterol, a crucial component of the fungal cellular membrane (Zhang et al. <a href="#CR63" class="usa-link" aria-describedby="CR63">2019</a>; Zonios and Bennett <a href="#CR65" class="usa-link" aria-describedby="CR65">2008</a>). The lack of ergosterol increases membrane permeability, ultimately leading to cell lysis (Herrick et al. <a href="#CR26" class="usa-link" aria-describedby="CR26">2025</a>).</p>
<p id="Par18">Itraconazole was the comparator drug in the first ever clinical trial for eumycetoma and using the standard regimen depicted in Fig. <a href="#Fig3" class="usa-link">3</a>. After 12 months of treatment an 80% cure-rate was obtained in the 30 patients in the modified intention-to-treat group (Fahal et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2024</a>). However, when looking at the treatment response before surgery, no significant differences in the clinical appearance of the lesion between the start of itraconazole treatment and 6 months into therapy were noted (Fahal et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2024</a>). Symptoms such as swelling, sinus formation, discharge, and pain did not decrease significantly after 6 months of treatment (Fahal et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2024</a>). Furthermore, (1–3)-β-D-glucan serum levels did not decrease during the first 6 months of therapy, but decreased after surgery (Nyuykonge et al. <a href="#CR43" class="usa-link" aria-describedby="CR43">2023</a>, <a href="#CR44" class="usa-link" aria-describedby="CR44">2024</a>; Tissot et al. <a href="#CR50" class="usa-link" aria-describedby="CR50">2013</a>). In clinical practice, the high cure rates reported in the clinical trial are not found. In a case series in which 377 eumycetoma patients infected with <em>M. mycetomatis</em> were followed, a corrected cure rate of only 67.6% was noted (van de Sande and Fahal <a href="#CR54" class="usa-link" aria-describedby="CR54">2024</a>). Furthermore, 23 (6.1%) of patients had to undergo amputation (van de Sande and Fahal <a href="#CR54" class="usa-link" aria-describedby="CR54">2024</a>; Wadal et al. <a href="#CR58" class="usa-link" aria-describedby="CR58">2016</a>). Moreover, itraconazole treatment is limited by poor availability in endemic regions. In developing countries, treatment response rates are low due to several factors, including drug resistance, high costs, limited drug access, and toxic side effects (Elkheir et al. <a href="#CR16" class="usa-link" aria-describedby="CR16">2020</a>; Kyriakidis et al. <a href="#CR30" class="usa-link" aria-describedby="CR30">2017</a>; Zein et al. <a href="#CR62" class="usa-link" aria-describedby="CR62">2012</a>). These challenges often lead to patient non-compliance, increasing the risk of disease recurrence and, in severe cases, amputation (Zein et al. <a href="#CR62" class="usa-link" aria-describedby="CR62">2012</a>).</p></section><section id="FPar2"><h5 class="pmc_sec_title">Terbinafine</h5>
<p id="Par19">When azoles are not available, terbinafine is often used as an alternative treatment for mycetoma, again in combination with surgery. Terbinafine inhibits squalene epoxidase in fungi, resulting in sterol deficiency and the toxic intracellular accumulation of squalene (Ryder <a href="#CR45" class="usa-link" aria-describedby="CR45">1992</a>). It is effective against <em>M. mycetomatis,</em> with a minimum inhibitory concentration (MIC) between 1—&gt; 16 µg/mL in vitro (van Belkum et al. <a href="#CR52" class="usa-link" aria-describedby="CR52">2011</a>). In <em>M. mycetomatis-</em>infected larvae, terbinafine was able to prolong survival compared to itraconazole and no treatment. In a small open-labeled study, 20 patients with eumycetoma caused by <em>M. mycetomatis, F. senegalensis,</em> and two unidentified fungal species were treated with 500 mg terbinafine twice per day for 24–48 weeks. Of these, 16 patients (80%) were either cured or showed clinical improvement without the need for surgery (N'Diaye et al. <a href="#CR40" class="usa-link" aria-describedby="CR40">2006</a>). In a retrospective study, terbinafine in combination with surgery has a cure rate of 55.6% (Sow et al. <a href="#CR49" class="usa-link" aria-describedby="CR49">2020</a>). Terbinafine is well tolerated, with no reports of severe adverse effects (N'Diaye et al. <a href="#CR40" class="usa-link" aria-describedby="CR40">2006</a>).</p></section><section id="FPar3"><h5 class="pmc_sec_title">Surgery</h5>
<p id="Par20">Despite the availability of treatments such as itraconazole and terbinafine, they need to be combined with surgery to achieve effective results. Small lesions (&lt; 5 cm) are removed by a wide surgical excision and closed using primary skin closure (Gismalla et al. <a href="#CR24" class="usa-link" aria-describedby="CR24">2024</a>). Removal of big lesions (&gt; 10 cm) is generally followed by reconstructive surgery, involving a skin graft or flap (Gismalla et al. <a href="#CR24" class="usa-link" aria-describedby="CR24">2024</a>). When eumycetoma has reached the bone, major surgery or reconstruction is usually ineffective due to the high likelihood of recurrence (Zein et al. <a href="#CR62" class="usa-link" aria-describedby="CR62">2012</a>). As a result, amputation is often performed (Gismalla et al. <a href="#CR24" class="usa-link" aria-describedby="CR24">2024</a>).</p></section></section></section><section id="Sec10"><h3 class="pmc_sec_title">Drug discovery for mycetoma</h3>
<p id="Par21">Since the current treatment options are lengthy, include both antifungal therapy and surgery, and often have a poor clinical outcome in daily practice there is an urgent need for a new and effective treatment for eumycetoma—one that is affordable and eliminates the need for surgery. However, neglected diseases like eumycetoma often receive limited prioritization and support in the search for new treatments. In the recent years there have been a few efforts to find a new drug for mycetoma. Figure <a href="#Fig4" class="usa-link">4</a> provides an overview of the modes of action of current and novel antifungal treatments for eumycetoma.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364754_253_2025_13580_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9196/12364754/a4aa7034558d/253_2025_13580_Fig4_HTML.jpg" loading="lazy" id="MO4" height="423" width="678" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>An overview of a fungal cell showing the compounds and their targets discussed. Antifungal compounds are in green. The drugs in green demonstrate current antifungal treatment for eumycetoma, and the drugs in pink are the novel treatments that are being investigated. Due to the significant toxicity, amphotericin B is no longer used in the treatment of eumycetoma(Laniado-Laborín and Cabrales-Vargas <a href="#CR31" class="usa-link" aria-describedby="CR31">2009</a>). Figure made with Biorender</p></figcaption></figure></section></section><section id="Sec11"><h2 class="pmc_sec_title">Repurposing drugs</h2>
<section id="Sec12"><h3 class="pmc_sec_title">Antifungal agents</h3>
<section id="Sec13"><h4 class="pmc_sec_title">Other azoles</h4>
<p id="Par22">Posaconazole (FDA approved in 2006), has demonstrated potent inhibitory activity against <em>M. mycetomatis</em> with an IC50 &lt; 0.098 µM (Lim et al. <a href="#CR32" class="usa-link" aria-describedby="CR32">2018</a>). In vivo<em>,</em> posaconazole significantly increased survival in <em>M. mycetomatis-</em>infected <em>G. mellonella</em> larvae by more than 20% (Lim et al. <a href="#CR32" class="usa-link" aria-describedby="CR32">2018</a>)(Fig. <a href="#Fig5" class="usa-link">5</a>). The efficacy and safety of posaconazole has been investigated in patients with eumycetoma. In one study, six patients (3 with <em>T. grisea,</em> 2 with <em>M. mycetomatis,</em> 1 with <em>S. boydii)</em> received 200–800 mg/day for up to 34 months (Negroni et al. <a href="#CR41" class="usa-link" aria-describedby="CR41">2005</a>). Five out of the six patients were successfully healed from eumycetoma without surgical intervention, and no long-term effects were reported. Another study using posaconazole 400 mg twice daily reported a higher rate of complete healing. However, both studies had small sample sizes, limiting the strength of their conclusions (Crabol et al. <a href="#CR13" class="usa-link" aria-describedby="CR13">2014</a>). A major drawback of posaconazole is its high cost, making it largely inaccessible in low resources areas, where eumycetoma is most prevalent.</p>
<figure class="fig xbox font-sm" id="Fig5"><h5 class="obj_head">Fig. 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12364754_253_2025_13580_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9196/12364754/65bbdb66d0d7/253_2025_13580_Fig5_HTML.jpg" loading="lazy" id="MO5" height="170" width="676" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Summary of antifungal compounds and their effectiveness against <em>M. mycetomatis</em> in vitro and in vivo. Green signifies that compound is potent, red signifies no potency</p></figcaption></figure><p id="Par23">Ravuconazole exhibited strong efficacy against <em>M. mycetomatis</em> with &lt; 0.098 µM (Nakano et al. <a href="#CR39" class="usa-link" aria-describedby="CR39">2019</a>) In <em>G. mellonella,</em> ravuconazole also prolonged larval survival (Lim et al. <a href="#CR34" class="usa-link" aria-describedby="CR34">2022b</a>) (Fig. <a href="#Fig5" class="usa-link">5</a>). Fosravuconazole, the prodrug of ravuconazole was originally developed for the treatment of onychomycosis, a fungal infection of the nails. Due to its potent in vitro and in vivo activity against <em>M. mycetomatis,</em> it was selected for the first clinial trial in mycetoma patients. In this clinical trial, patients received either 200 mg/week or 300 mg/week fosravuconazole for 6 months, followed by surgical lesion removal, and 6 additional months of post-treatment with fosravuconazole (Fahal et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2024</a>). This regimen was compared to the standard itraconazole treatment of 400 mg/week combined with surgery. The results showed that weekly doses of 200 or 300 mg had a cure rate of 85% or 65%, respectively and were not significantly more effective than itraconazole (Fahal et al. <a href="#CR22" class="usa-link" aria-describedby="CR22">2024</a>). Since fosravuconazole requires only weekly dosing and itraconazole must be taken daily, further investigation into this treatment is worth exploring.</p>
<section id="FPar4"><h5 class="pmc_sec_title">Olorofim</h5>
<p id="Par24">Olorofim, a compound from the orotomides class, targets dihydroorotate dehydrogenase (DHODH), disrupting pyrimidine synthesis, DNA/RNA formation, protein synthesis and cell cycle regulation (Feuss et al. <a href="#CR23" class="usa-link" aria-describedby="CR23">2024</a>). Olorofim demonstrated an IC50 of &lt; 0.098 µM against <em>M. mycetomatis</em> and significantly prolonged the survival of infected larvae (Lim et al. <a href="#CR34" class="usa-link" aria-describedby="CR34">2022b</a>) (Fig. <a href="#Fig5" class="usa-link">5</a>). While olorofim shows promise for the treatment of <em>M. mycetomatis</em> caused eumycetoma, it has been less effective against other causative agents of eumycetoma, such as <em>F. senegalensis</em> and <em>M. romeroi,</em> likely due to differences in DHODH sequences among these species (Lim et al. <a href="#CR34" class="usa-link" aria-describedby="CR34">2022b</a>). Several clinical trials have been conducted to assess olorofim’s toxicity and efficacy against fungal infections, but no mycetoma patients were included. From the randomized, double-blind, placebo-controlled phase 1 clinical trial registered on 20 May 2015 and which investigated the tolerability of olorofim in 40 healthy male volunteers, it was shown that with olorofim only minor adverse events were noted such as headaches, eczema, or epistaxis (<a href="https://clinicaltrials.gov/ct2/show/NCT02142153" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT02142153</a>) (ClinicalTrials.gov <a href="#CR11" class="usa-link" aria-describedby="CR11">2015</a>). No severe adverse effects were experienced. A follow-up clinical trial will commence in the near future to investigate the effect of olorofim against invasive aspergillosis (<a href="https://clinicaltrials.gov/ct2/show/NCT05101187" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NCT05101187</a>) (ClinicalTrials.gov <a href="#CR12" class="usa-link" aria-describedby="CR12">2024</a>). While the promising results from early trials suggest potential for olorofim, further in vivo studies are warranted before advancing to human trials for the treatment of eumycetoma.</p></section><section id="FPar5"><h5 class="pmc_sec_title">Manogepix</h5>
<p id="Par25">Manogepix inhibits GWT1, an enzyme in the glycosylphosphatidylinositol (GPI)-anchor biosynthesis pathway, resulting in the disruption of mannoproteins formation, which are critical for the fungal cell wall (Watanabe et al. <a href="#CR59" class="usa-link" aria-describedby="CR59">2012</a>). For eumycetoma causative agents, manogepix had an IC50 of 4 mg/L and reduced the hyphal and biofilm formation (Konings et al. <a href="#CR29" class="usa-link" aria-describedby="CR29">2023</a>). Synergy was observed between manogepix and itraconazole in vitro. However, no prolonged survival was observed when <em>M. mycetaomtis</em> infected <em>G. mellonella</em> larvae were treated with either manogepix alone or a combination of manogepix and itraconazole (Konings et al. <a href="#CR29" class="usa-link" aria-describedby="CR29">2023</a>) (Fig. <a href="#Fig5" class="usa-link">5</a>).</p></section><section id="FPar6"><h5 class="pmc_sec_title">Ibrexafungerp</h5>
<p id="Par26">Ibrexafungerp (FDA approved in 2021) is a novel triterpenoid antifungal that targets β-(1,3)-D-glucan synthase, thereby inhibiting the synthesis of β-(1,3)-D-glucan. It has been demonstrated to inhibit <em>M. mycetomatis</em> with an IC50 of 16 mg/L<em>.</em> Ibrexafungerp also prolonged larval survival at day 10 and decreased grain size in infected larvae (Ma <a href="#CR38" class="usa-link" aria-describedby="CR38">2025</a>). It is currently approved for the treatment of vaginal infections and its strong in vitro and in vivo activity suggests potential for repurposing in the treatment of eumycetoma.</p></section><section id="FPar7"><h5 class="pmc_sec_title">Repurposing other compounds</h5>
<p id="Par27">Medicines for Malaria Venture (MMV) has established Open Access compound libraries aimed at repurposing drugs for neglected tropical diseases (NTDs). These include the Pathogen Box, Stasis Box, Pandemic Box, COVID Box, and Global Health Priority Box. A total of 1,600 compounds from these MMV Open Access boxes were tested for their efficacy against <em>M. mycetomatis</em> in vitro (Lim et al. <a href="#CR32" class="usa-link" aria-describedby="CR32">2018</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">2022b</a>; Ma et al. <a href="#CR37" class="usa-link" aria-describedby="CR37">2024</a>). Among them, 29 compounds demonstrated an IC50 below 10 µM, including 15 from the pandemic box, 10 from the pathogen box, three from the global health priority box and one from the stasis box. Of these 29 compounds, 10 significantly increased survival in <em>M. mycetomatis-</em>infected <em>G. mellonella</em> larvae. Among the most promising compounds identified were azole antifungals, including posaconazole, bitertanol, and ravuconazole. All of which exhibited an IC50 &lt; 10 µM against <em>M. mycetomatis.</em></p>
<p id="Par28">Another class of potential compounds identified from the MMV boxes, were the benzimidazoles (Lim et al. <a href="#CR34" class="usa-link" aria-describedby="CR34">2022b</a>). Benzimidazole fenbendazole and MMV1782387, were identified as potent inhibitors of <em>M. mycetomatis.</em> Fenbendazole, commonly used as an anthelmintic in veterinary medicine, demonstrated an IC50 of 3 µM and significantly prolonged the survival of infected larvae (Lim et al. <a href="#CR34" class="usa-link" aria-describedby="CR34">2022b</a>)<em>.</em> Benzimidazoles bind to β-tubulin, destabilizing microtubule formation, which impairs cell division and motility (Dogra et al. <a href="#CR14" class="usa-link" aria-describedby="CR14">2018</a>). MMV1782387 exhibited an IC50 of 3 µM and significantly improved larvae survival (Lim et al. <a href="#CR34" class="usa-link" aria-describedby="CR34">2022b</a>).</p>
<p id="Par29">MMV006357, a 2-aminothiazole derivative, has an IC50 of 0.4 µM (Lim et al. <a href="#CR32" class="usa-link" aria-describedby="CR32">2018</a>). Abafungin, another 2-aminothiazole derivative, is known to inhibit sterol C-24 methyltransferase, resulting in ergosterol impairment of the fungal cell membrane (Borelli et al. <a href="#CR5" class="usa-link" aria-describedby="CR5">2008</a>).</p>
<p id="Par30">Other compounds that were potent in vitro and in vivo coming from MMV boxes were MMV22478, MMV675968 and MMV1804559 (IC50 = 2.95 µM, 2.3 µM and 6.95 µM, respectively). MMV022478 and MMV1804559, both pyrazolopyrimidines, showed prolonged survival in infected larvae early in infection (Ma et al. <a href="#CR37" class="usa-link" aria-describedby="CR37">2024</a>). MMV1804599 also resulted in fewer and smaller grains in vivo. When combined with itraconazole, MMV1804599 enhanced therapeutic efficacy in infected larvae (Ma et al. <a href="#CR37" class="usa-link" aria-describedby="CR37">2024</a>). And lastly, MMV675968, a quinazoline, inhibits dihydrofolate reductase (DHFR), which is crucial for DNA and RNA repair, replication and methylation, as well as cell proliferation and cell growth (Lim et al. <a href="#CR32" class="usa-link" aria-describedby="CR32">2018</a>, <a href="#CR35" class="usa-link" aria-describedby="CR35">2022c</a>).</p></section><section id="FPar8"><h5 class="pmc_sec_title">MycetOS</h5>
<p id="Par31">The Mycetoma Open Source (MycetOS) is an innovative open science initiative dedicated to developing and testing new compounds in vitro and in vivo<em>.</em> Research data is openly shared on Github in real time. What sets MycetOS apart is its inclusivity, engaging scientists at all levels, from professors to high school students, who help synthesize the compounds.</p>
<p id="Par32">A key series of compounds tested are fenarimols, which are known to inhibit the ergosterol biosynthesis pathway. Initially, MMV689244, a compound from the Pathogen Box, was identified as a hit with an in vitro IC50 of 1.35 µM against <em>M. mycetomatis </em>(Lim et al. <a href="#CR32" class="usa-link" aria-describedby="CR32">2018</a>). Following this, 35 fenarimols analogs were tested in vitro against <em>M. mycetomatis.</em> Five fenarimol analogs demonstrated significant inhibitory activity against <em>M. mycetomatis,</em> and three analogs prolonged the survival of infected larvae (Lim et al. <a href="#CR32" class="usa-link" aria-describedby="CR32">2018</a>). These findings correlate with the compounds’ lipophilicity (logD), revealing that compounds with a logD below 2.5 at pH 7.4 were more likely to effectively penetrate the grain, a critical factor for therapeutic efficacy (Lim et al. <a href="#CR32" class="usa-link" aria-describedby="CR32">2018</a>). Since then, a total of 194 fenarimol analogs have been synthesized and tested within the MycetOS project. Of these, 30 compounds displayed inhibitory activity against <em>M. mycetomatis</em> in vitro<em>,</em> and six of them significantly prolonged larval survival. However, it is important to note that fenarimols have thus far shown potent activity exclusively against <em>M. mycetomatis,</em> with no efficacy against other causative agents of eumycetoma.</p>
<p id="Par33">Another promising class of compounds under investigation in MycetOS is benzimidazoles carbanates. This series was started based on two hits earlier discussed, fenbendazole and MMV1782387 (Lim et al. <a href="#CR34" class="usa-link" aria-describedby="CR34">2022b</a>). To date, 83 benzimidazole analogs have been synthesized, with 22 exhibiting inhibitory activity against <em>M. mycetomatis</em> in vitro<em>.</em> Two of these compounds have also shown the ability to prolong larval survival, not yet published (Todd <a href="#CR51" class="usa-link" aria-describedby="CR51">2025</a>).</p>
<p id="Par34">Additionally, ongoing work in MycetOS includes the exploration of other compound classes, such as aminothiazoles, phenothiazines, and ketoximines. The progress of these series and detailed data on their in vitro and in vivo activities can be found in the MycetOS repository on GitHub.</p></section></section></section></section><section id="Sec19"><h2 class="pmc_sec_title">In conclusion</h2>
<p id="Par35">Eumycetoma remains a significant public health challenge in endemic regions, demanding more accessible diagnostic and therapeutic strategies. Despite advances in understanding its pathogenesis and immune response, the disease remains difficult to treat. While many of the novel antifungals mentioned here show promise for treating eumycetoma, the search for more potent compounds continues. The MycetOS initiative is dedicated to developing and testing new compounds in vitro and in vivo to identify potential hits. These novel agents aim to improve safety profiles, reduce drug interactions, enhance potency, and ensure accessibility in the endemic regions.</p></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>D.E. wrote the draft manuscript, T.B and W.S. reviewed and revised the manuscript. All authors reviewed the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>The authors received funding from VICI grant 09150182310010 from the Dutch Scientific Organization (NWO) awarded to Wendy W.J. van de Sande. The funders had no role in the construction of this review or the decision to publish.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>No datasets were generated or analysed during the current study.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar10"><h3 class="pmc_sec_title">Ethical approval</h3>
<p id="Par36">Not applicable.</p></section><section id="FPar11"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par37">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher's note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References
</h2>
<section id="Bib1_sec2"><ol class="ref-list font-sm">
<li id="CR1">
<cite>Abd El Bagi ME (2003) New radiographic classification of bone involvement in pedal mycetoma. AJR Am J Roentgenol 180(3):665–668
</cite> [<a href="https://doi.org/10.2214/ajr.180.3.1800665" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12591671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Abd%20El%20Bagi%20ME%20(2003)%20New%20radiographic%20classification%20of%20bone%20involvement%20in%20pedal%20mycetoma.%20AJR%20Am%20J%20Roentgenol%20180(3):665%E2%80%93668" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<cite> Abugessaisa I, Konings M, Manabe R-I, Kawashima T, Hasegawa A, Takahashi C, Tagami M, Okazaki Y, Lim W, Verbon A, Fahal AH, Kasukawa T, van de Sande WWJ (2022) Iron regulatory pathways differentially expressed during Madurella mycetomatis grain development in Galleria mellonella. bioRxiv:2022.12.20.520897. 10.1101/2022.12.20.520897</cite> [<a href="https://doi.org/10.1038/s41467-025-60875-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12198395/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40562743/" class="usa-link">PubMed</a>]</li>
<li id="CR3">
<cite>Ahmed AO, van Leeuwen W, Fahal A, van de Sande W, Verbrugh H, van Belkum A (2004) Mycetoma caused by <em>Madurella mycetomatis</em>: a neglected infectious burden. Lancet Infect Dis 4(9):566–574
</cite> [<a href="https://doi.org/10.1016/S1473-3099(04)01131-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15336224/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ahmed%20AO,%20van%20Leeuwen%20W,%20Fahal%20A,%20van%20de%20Sande%20W,%20Verbrugh%20H,%20van%20Belkum%20A%20(2004)%20Mycetoma%20caused%20by%20Madurella%20mycetomatis:%20a%20neglected%20infectious%20burden.%20Lancet%20Infect%20Dis%204(9):566%E2%80%93574" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<cite>Ahmed SA, González GM, Tirado-Sánchez A, Moreno-López LM, de Hoog S, Bonifaz A (2018) <em>Nigrograna mackinnonii</em>, not <em>Trematosphaeria grisea</em> (syn., <em>Madurella grisea</em>), is the main agent of black grain eumycetoma in Latin America. J Clin Microbiol. 10.1128/JCM.01723-17
</cite> [<a href="https://doi.org/10.1128/JCM.01723-17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5824062/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29263207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ahmed%20SA,%20Gonz%C3%A1lez%20GM,%20Tirado-S%C3%A1nchez%20A,%20Moreno-L%C3%B3pez%20LM,%20de%20Hoog%20S,%20Bonifaz%20A%20(2018)%20Nigrograna%20mackinnonii,%20not%20Trematosphaeria%20grisea%20(syn.,%20Madurella%20grisea),%20is%20the%20main%20agent%20of%20black%20grain%20eumycetoma%20in%20Latin%20America.%20J%20Clin%20Microbiol.%2010.1128/JCM.01723-17" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<cite>Borelli C, Schaller M, Niewerth M, Nocker K, Baasner B, Berg D, Tiemann R, Tietjen K, Fugmann B, Lang-Fugmann S, Korting HC (2008) Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi. Chemotherapy 54(4):245–259
</cite> [<a href="https://doi.org/10.1159/000142334" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2818358/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18587237/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Borelli%20C,%20Schaller%20M,%20Niewerth%20M,%20Nocker%20K,%20Baasner%20B,%20Berg%20D,%20Tiemann%20R,%20Tietjen%20K,%20Fugmann%20B,%20Lang-Fugmann%20S,%20Korting%20HC%20(2008)%20Modes%20of%20action%20of%20the%20new%20arylguanidine%20abafungin%20beyond%20interference%20with%20ergosterol%20biosynthesis%20and%20in%20vitro%20activity%20against%20medically%20important%20fungi.%20Chemotherapy%2054(4):245%E2%80%93259" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<cite>Browne N, Heelan M, Kavanagh K (2013) An analysis of the structural and functional similarities of insect hemocytes and mammalian phagocytes. Virulence 4(7):597–603
</cite> [<a href="https://doi.org/10.4161/viru.25906" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3906293/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23921374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Browne%20N,%20Heelan%20M,%20Kavanagh%20K%20(2013)%20An%20analysis%20of%20the%20structural%20and%20functional%20similarities%20of%20insect%20hemocytes%20and%20mammalian%20phagocytes.%20Virulence%204(7):597%E2%80%93603" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<cite>Cárdenas-de la Garza JA, Welsh O, Cuéllar-Barboza A, Suarez-Sánchez KP, De la Cruz-Valadez E, Cruz-Gómez LG, Gallardo-Rocha A, Ocampo-Candiani J, Vera-Cabrera L (2020) Clinical characteristics and treatment of actinomycetoma in northeast Mexico: a case series. PLoS Negl Trop Dis 14(2):e0008123
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0008123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7059949/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32097417/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?C%C3%A1rdenas-de%20la%20Garza%20JA,%20Welsh%20O,%20Cu%C3%A9llar-Barboza%20A,%20Suarez-S%C3%A1nchez%20KP,%20De%20la%20Cruz-Valadez%20E,%20Cruz-G%C3%B3mez%20LG,%20Gallardo-Rocha%20A,%20Ocampo-Candiani%20J,%20Vera-Cabrera%20L%20(2020)%20Clinical%20characteristics%20and%20treatment%20of%20actinomycetoma%20in%20northeast%20Mexico:%20a%20case%20series.%20PLoS%20Negl%20Trop%20Dis%2014(2):e0008123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8"><cite> CDC (2024a) Clinical Overview of Mycetoma. PUblisher. <a href="https://archive.cdc.gov/www_cdc_gov/fungal/diseases/mycetoma/health-professionals.html#:~:text=Eumycetoma%20is%20less%20responsive%20to,cultured%20from%20lesions%20post%2Dtreatment" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://archive.cdc.gov/www_cdc_gov/fungal/diseases/mycetoma/health-professionals.html#:~:text=Eumycetoma%20is%20less%20responsive%20to,cultured%20from%20lesions%20post%2Dtreatment</a>. Accessed 25/03 2025</cite></li>
<li id="CR9"><cite> CDC (2024b) Mycetoma Basics. PUblisher. <a href="https://www.cdc.gov/mycetoma/about/index.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cdc.gov/mycetoma/about/index.html</a> Accessed 25/03 2025</cite></li>
<li id="CR10">
<cite>Clark JE, Kim HY, van de Sande WWJ, McMullan B, Verweij P, Alastruey-Izquierdo A, Chakrabarti A, Harrison TS, Bongomin F, Hay RJ, Oladele R, Heim J, Beyer P, Galas M, Siswanto S, Dagne DA, Roitberg F, Gigante V, Beardsley J, Sati H, Alffenaar JW, Morrissey CO (2024) Eumycetoma causative agents: a systematic review to inform the World Health Organization priority list of fungal pathogens. Med Mycol. 10.1093/mmy/myae044
</cite> [<a href="https://doi.org/10.1093/mmy/myae044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11210612/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38935904/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Clark%20JE,%20Kim%20HY,%20van%20de%20Sande%20WWJ,%20McMullan%20B,%20Verweij%20P,%20Alastruey-Izquierdo%20A,%20Chakrabarti%20A,%20Harrison%20TS,%20Bongomin%20F,%20Hay%20RJ,%20Oladele%20R,%20Heim%20J,%20Beyer%20P,%20Galas%20M,%20Siswanto%20S,%20Dagne%20DA,%20Roitberg%20F,%20Gigante%20V,%20Beardsley%20J,%20Sati%20H,%20Alffenaar%20JW,%20Morrissey%20CO%20(2024)%20Eumycetoma%20causative%20agents:%20a%20systematic%20review%20to%20inform%20the%20World%20Health%20Organization%20priority%20list%20of%20fungal%20pathogens.%20Med%20Mycol.%2010.1093/mmy/myae044" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11"><cite> ClinicalTrials.gov (2015) F901318 Single Ascending Dose Study in Healthy Male Volunteers. PUblisher. <a href="https://www.clinicaltrials.gov/study/NCT02142153?cond=olorofim&amp;page=2&amp;rank=16&amp;tab=results" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.clinicaltrials.gov/study/NCT02142153?cond=olorofim&amp;page=2&amp;rank=16&amp;tab=results</a>. Accessed 01-08-2025</cite></li>
<li id="CR12"><cite> ClinicalTrials.gov (2024) Olorofim Aspergillus Infection Study (OASIS). PUblisher. <a href="https://www.clinicaltrials.gov/study/NCT05101187?cond=olorofim&amp;page=1&amp;rank=1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.clinicaltrials.gov/study/NCT05101187?cond=olorofim&amp;page=1&amp;rank=1</a>. Accessed 01-08-2025</cite></li>
<li id="CR13">
<cite>Crabol Y, Poiree S, Bougnoux ME, Maunoury C, Barete S, Zeller V, Arvieux C, Pineau S, Amazzough K, Lecuit M, Lanternier F, Lortholary O, French Mycosis Study G (2014) Last generation triazoles for imported eumycetoma in eleven consecutive adults. PLoS Negl Trop Dis 8(10):e3232
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0003232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4191942/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25299610/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Crabol%20Y,%20Poiree%20S,%20Bougnoux%20ME,%20Maunoury%20C,%20Barete%20S,%20Zeller%20V,%20Arvieux%20C,%20Pineau%20S,%20Amazzough%20K,%20Lecuit%20M,%20Lanternier%20F,%20Lortholary%20O,%20French%20Mycosis%20Study%20G%20(2014)%20Last%20generation%20triazoles%20for%20imported%20eumycetoma%20in%20eleven%20consecutive%20adults.%20PLoS%20Negl%20Trop%20Dis%208(10):e3232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<cite>Dogra N, Kumar A, Mukhopadhyay T (2018) Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways. Sci Rep 8(1):11926
</cite> [<a href="https://doi.org/10.1038/s41598-018-30158-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6085345/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30093705/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dogra%20N,%20Kumar%20A,%20Mukhopadhyay%20T%20(2018)%20Fenbendazole%20acts%20as%20a%20moderate%20microtubule%20destabilizing%20agent%20and%20causes%20cancer%20cell%20death%20by%20modulating%20multiple%20cellular%20pathways.%20Sci%20Rep%208(1):11926" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<cite>El-Amin SO, El-Amin RO, El-Sadig SM, Fahal AH, Musa A (2024) Painful mycetoma: a study to understand the risk factors in patients visiting the Mycetoma Research Centre (MRC) in Khartoum, Sudan. Trans R Soc Trop Med Hyg. 10.1093/trstmh/trae093</cite> [<a href="https://doi.org/10.1093/trstmh/trae093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39611590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?El-Amin%20SO,%20El-Amin%20RO,%20El-Sadig%20SM,%20Fahal%20AH,%20Musa%20A%20(2024)%20Painful%20mycetoma:%20a%20study%20to%20understand%20the%20risk%20factors%20in%20patients%20visiting%20the%20Mycetoma%20Research%20Centre%20(MRC)%20in%20Khartoum,%20Sudan.%20Trans%20R%20Soc%20Trop%20Med%20Hyg.%2010.1093/trstmh/trae093" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<cite>Elkheir LYM, Haroun R, Mohamed MA, Fahal AH (2020) <em>Madurella mycetomatis</em> causing eumycetoma medical treatment: the challenges and prospects. PLoS Negl Trop Dis 14(8):e0008307
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0008307" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7452721/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32853199/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Elkheir%20LYM,%20Haroun%20R,%20Mohamed%20MA,%20Fahal%20AH%20(2020)%20Madurella%20mycetomatis%20causing%20eumycetoma%20medical%20treatment:%20the%20challenges%20and%20prospects.%20PLoS%20Negl%20Trop%20Dis%2014(8):e0008307" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<cite>Emery D, Denning DW (2020) The global distribution of actinomycetoma and eumycetoma. PLoS Negl Trop Dis 14(9):e0008397
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0008397" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7514014/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32970667/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Emery%20D,%20Denning%20DW%20(2020)%20The%20global%20distribution%20of%20actinomycetoma%20and%20eumycetoma.%20PLoS%20Negl%20Trop%20Dis%2014(9):e0008397" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<cite>Fahal AH, Bakhiet SM (2023) Mycetoma and the environment. PLoS Negl Trop Dis 17(11):e0011736
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0011736" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10653480/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37971968/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fahal%20AH,%20Bakhiet%20SM%20(2023)%20Mycetoma%20and%20the%20environment.%20PLoS%20Negl%20Trop%20Dis%2017(11):e0011736" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<cite>Fahal AH, Rahman IA, El-Hassan AM, Rahman ME, Zijlstra EE (2011) The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to <em>Madurella mycetomatis</em>. Trans R Soc Trop Med Hyg 105(3):127–132
</cite> [<a href="https://doi.org/10.1016/j.trstmh.2010.11.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21247608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fahal%20AH,%20Rahman%20IA,%20El-Hassan%20AM,%20Rahman%20ME,%20Zijlstra%20EE%20(2011)%20The%20safety%20and%20efficacy%20of%20itraconazole%20for%20the%20treatment%20of%20patients%20with%20eumycetoma%20due%20to%20Madurella%20mycetomatis.%20Trans%20R%20Soc%20Trop%20Med%20Hyg%20105(3):127%E2%80%93132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<cite>Fahal A, el Mahgoub S, El Hassan AM, Abdel-Rahman ME (2015) Mycetoma in the Sudan: an update from the Mycetoma Research Centre, University of Khartoum, Sudan. PLoS Negl Trop Dis 9(3):e0003679
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0003679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4376889/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25816316/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fahal%20A,%20el%20Mahgoub%20S,%20El%20Hassan%20AM,%20Abdel-Rahman%20ME%20(2015)%20Mycetoma%20in%20the%20Sudan:%20an%20update%20from%20the%20Mycetoma%20Research%20Centre,%20University%20of%20Khartoum,%20Sudan.%20PLoS%20Negl%20Trop%20Dis%209(3):e0003679" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<cite>Fahal AH, Suliman SH, Hay R (2018) Mycetoma: the spectrum of clinical presentation. Trop Med Infect Dis. 10.3390/tropicalmed3030097
</cite> [<a href="https://doi.org/10.3390/tropicalmed3030097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6161195/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30274493/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fahal%20AH,%20Suliman%20SH,%20Hay%20R%20(2018)%20Mycetoma:%20the%20spectrum%20of%20clinical%20presentation.%20Trop%20Med%20Infect%20Dis.%2010.3390/tropicalmed3030097" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<cite>Fahal AH, Ahmed ES, Bakhiet SM, Bakhiet OE, Fahal LA, Mohamed AA, Mohamedelamin ESW, Bahar MEN, Attalla HY, Siddig EE, Mhmoud NA, Musa AM, van de Sande WWJ, Scherrer B, Oyieko P, Egondi TW, Onyango KO, Hata K, Chu WY, Dorlo TPC, Brüggemann RJ, Nyaoke BA, Strub-Wourgaft N, Zijlstra EE (2024) Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial. Lancet Infect Dis 24(11):1254–1265
</cite> [<a href="https://doi.org/10.1016/S1473-3099(24)00404-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39098321/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Fahal%20AH,%20Ahmed%20ES,%20Bakhiet%20SM,%20Bakhiet%20OE,%20Fahal%20LA,%20Mohamed%20AA,%20Mohamedelamin%20ESW,%20Bahar%20MEN,%20Attalla%20HY,%20Siddig%20EE,%20Mhmoud%20NA,%20Musa%20AM,%20van%20de%20Sande%20WWJ,%20Scherrer%20B,%20Oyieko%20P,%20Egondi%20TW,%20Onyango%20KO,%20Hata%20K,%20Chu%20WY,%20Dorlo%20TPC,%20Br%C3%BCggemann%20RJ,%20Nyaoke%20BA,%20Strub-Wourgaft%20N,%20Zijlstra%20EE%20(2024)%20Two%20dose%20levels%20of%20once-weekly%20fosravuconazole%20versus%20daily%20itraconazole%20in%20combination%20with%20surgery%20in%20patients%20with%20eumycetoma%20in%20Sudan:%20a%20randomised,%20double-blind,%20phase%202,%20proof-of-concept%20superiority%20trial.%20Lancet%20Infect%20Dis%2024(11):1254%E2%80%931265" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<cite>Feuss A, Bougnoux ME, Dannaoui E (2024) The role of Olorofim in the treatment of filamentous fungal infections: a review of in vitro and in vivo studies. J Fungi. 10.3390/jof10050345</cite> [<a href="https://doi.org/10.3390/jof10050345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11121921/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38786700/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feuss%20A,%20Bougnoux%20ME,%20Dannaoui%20E%20(2024)%20The%20role%20of%20Olorofim%20in%20the%20treatment%20of%20filamentous%20fungal%20infections:%20a%20review%20of%20in%20vitro%20and%20in%20vivo%20studies.%20J%20Fungi.%2010.3390/jof10050345" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<cite>Gismalla MDA, Bakhiet MY, Alshareef AM, Saadeldien MSM, Ahmed GMA, Adam AMI, Abuelnour AEK (2024) Reconstructive surgery for mycetoma: preliminary algorithm and a systematic review. JPRAS Open 40:130–137
</cite> [<a href="https://doi.org/10.1016/j.jpra.2024.02.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11156701/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38854620/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gismalla%20MDA,%20Bakhiet%20MY,%20Alshareef%20AM,%20Saadeldien%20MSM,%20Ahmed%20GMA,%20Adam%20AMI,%20Abuelnour%20AEK%20(2024)%20Reconstructive%20surgery%20for%20mycetoma:%20preliminary%20algorithm%20and%20a%20systematic%20review.%20JPRAS%20Open%2040:130%E2%80%93137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<cite>Hassan R, Simpson H, Cano J, Bakhiet S, Ganawa E, Argaw D, Newport MJ, Deribe K, Fahal AH (2021) Modelling the spatial distribution of mycetoma in Sudan. Trans R Soc Trop Med Hyg 115(10):1144–1152
</cite> [<a href="https://doi.org/10.1093/trstmh/trab076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8486737/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34037803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hassan%20R,%20Simpson%20H,%20Cano%20J,%20Bakhiet%20S,%20Ganawa%20E,%20Argaw%20D,%20Newport%20MJ,%20Deribe%20K,%20Fahal%20AH%20(2021)%20Modelling%20the%20spatial%20distribution%20of%20mycetoma%20in%20Sudan.%20Trans%20R%20Soc%20Trop%20Med%20Hyg%20115(10):1144%E2%80%931152" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<cite>Herrick EJ, Patel P, Hashmi MF (2025) Antifungal ergosterol synthesis inhibitors. In: StatPearls. 
<a href="https://www.ncbi.nlm.nih.gov/books/NBK551581/" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.ncbi.nlm.nih.gov/books/NBK551581/</a></cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/31869062/" class="usa-link">PubMed</a>]</li>
<li id="CR27">
<cite>Ibrahim AI, El Hassan AM, Fahal A, van de Sande WW (2013) A histopathological exploration of the <em>Madurella mycetomatis</em> grain. PLoS One 8(3):e57774
</cite> [<a href="https://doi.org/10.1371/journal.pone.0057774" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3590280/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23483927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ibrahim%20AI,%20El%20Hassan%20AM,%20Fahal%20A,%20van%20de%20Sande%20WW%20(2013)%20A%20histopathological%20exploration%20of%20the%20Madurella%20mycetomatis%20grain.%20PLoS%20One%208(3):e57774" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<cite>Kloezen W, van Helvert-van PM, Fahal AH, van de Sande WW (2015) A <em>Madurella mycetomatis</em> grain model in <em>Galleria mellonella</em> larvae. PLoS Negl Trop Dis 9(7):e0003926
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0003926" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4501544/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26173126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kloezen%20W,%20van%20Helvert-van%20PM,%20Fahal%20AH,%20van%20de%20Sande%20WW%20(2015)%20A%20Madurella%20mycetomatis%20grain%20model%20in%20Galleria%20mellonella%20larvae.%20PLoS%20Negl%20Trop%20Dis%209(7):e0003926" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<cite>Konings M, Eadie K, Strepis N, Nyuykonge B, Fahal AH, Verbon A, van de Sande WWJ (2023) The combination of manogepix and itraconazole is synergistic and inhibits the growth of <em>Madurella mycetomatis</em> in vitro but not in vivo. Med Mycol. 10.1093/mmy/myad118
</cite> [<a href="https://doi.org/10.1093/mmy/myad118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10684268/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37960934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Konings%20M,%20Eadie%20K,%20Strepis%20N,%20Nyuykonge%20B,%20Fahal%20AH,%20Verbon%20A,%20van%20de%20Sande%20WWJ%20(2023)%20The%20combination%20of%20manogepix%20and%20itraconazole%20is%20synergistic%20and%20inhibits%20the%20growth%20of%20Madurella%20mycetomatis%20in%20vitro%20but%20not%20in%20vivo.%20Med%20Mycol.%2010.1093/mmy/myad118" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<cite>Kyriakidis I, Tragiannidis A, Munchen S, Groll AH (2017) Clinical hepatotoxicity associated with antifungal agents. Expert Opin Drug Saf 16(2):149–165
</cite> [<a href="https://doi.org/10.1080/14740338.2017.1270264" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27927037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kyriakidis%20I,%20Tragiannidis%20A,%20Munchen%20S,%20Groll%20AH%20(2017)%20Clinical%20hepatotoxicity%20associated%20with%20antifungal%20agents.%20Expert%20Opin%20Drug%20Saf%2016(2):149%E2%80%93165" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<cite>Laniado-Laborín R, Cabrales-Vargas MN (2009) Amphotericin B: side effects and toxicity. Rev Iberoam Micol 26(4):223–227
</cite> [<a href="https://doi.org/10.1016/j.riam.2009.06.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19836985/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Laniado-Labor%C3%ADn%20R,%20Cabrales-Vargas%20MN%20(2009)%20Amphotericin%20B:%20side%20effects%20and%20toxicity.%20Rev%20Iberoam%20Micol%2026(4):223%E2%80%93227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<cite>Lim W, Melse Y, Konings M, Phat Duong H, Eadie K, Laleu B, Perry B, Todd MH, Ioset JR, van de Sande WWJ (2018) Addressing the most neglected diseases through an open research model: the discovery of fenarimols as novel drug candidates for eumycetoma. PLoS Negl Trop Dis 12(4):e0006437
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0006437" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5940239/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29698504/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lim%20W,%20Melse%20Y,%20Konings%20M,%20Phat%20Duong%20H,%20Eadie%20K,%20Laleu%20B,%20Perry%20B,%20Todd%20MH,%20Ioset%20JR,%20van%20de%20Sande%20WWJ%20(2018)%20Addressing%20the%20most%20neglected%20diseases%20through%20an%20open%20research%20model:%20the%20discovery%20of%20fenarimols%20as%20novel%20drug%20candidates%20for%20eumycetoma.%20PLoS%20Negl%20Trop%20Dis%2012(4):e0006437" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<cite>Lim W, Konings M, Parel F, Eadie K, Strepis N, Fahal A, Verbon A, van de Sande WWJ (2022) Inhibiting DHN- and DOPA-melanin biosynthesis pathway increased the therapeutic value of itraconazole in <em>Madurella mycetomatis</em> infected <em>Galleria mellonella</em>. Med Mycol. 10.1093/mmy/myac003
</cite> [<a href="https://doi.org/10.1093/mmy/myac003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9295015/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35064672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lim%20W,%20Konings%20M,%20Parel%20F,%20Eadie%20K,%20Strepis%20N,%20Fahal%20A,%20Verbon%20A,%20van%20de%20Sande%20WWJ%20(2022)%20Inhibiting%20DHN-%20and%20DOPA-melanin%20biosynthesis%20pathway%20increased%20the%20therapeutic%20value%20of%20itraconazole%20in%20Madurella%20mycetomatis%20infected%20Galleria%20mellonella.%20Med%20Mycol.%2010.1093/mmy/myac003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<cite>Lim W, Nyuykonge B, Eadie K, Konings M, Smeets J, Fahal A, Bonifaz A, Todd M, Perry B, Samby K, Burrows J, Verbon A, van de Sande W (2022) Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma. PLoS Negl Trop Dis 16(2):e0010159
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0010159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8815882/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35120131/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lim%20W,%20Nyuykonge%20B,%20Eadie%20K,%20Konings%20M,%20Smeets%20J,%20Fahal%20A,%20Bonifaz%20A,%20Todd%20M,%20Perry%20B,%20Samby%20K,%20Burrows%20J,%20Verbon%20A,%20van%20de%20Sande%20W%20(2022)%20Screening%20the%20pandemic%20response%20box%20identified%20benzimidazole%20carbamates,%20Olorofim%20and%20ravuconazole%20as%20promising%20drug%20candidates%20for%20the%20treatment%20of%20eumycetoma.%20PLoS%20Negl%20Trop%20Dis%2016(2):e0010159" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<cite>Lim W, Verbon A, van de Sande W (2022) Identifying novel drugs with new modes of action for neglected tropical fungal skin diseases (fungal skinNTDs) using an open source drug discovery approach. Expert Opin Drug Discov 17(6):641–659
</cite> [<a href="https://doi.org/10.1080/17460441.2022.2080195" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35612364/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lim%20W,%20Verbon%20A,%20van%20de%20Sande%20W%20(2022)%20Identifying%20novel%20drugs%20with%20new%20modes%20of%20action%20for%20neglected%20tropical%20fungal%20skin%20diseases%20(fungal%20skinNTDs)%20using%20an%20open%20source%20drug%20discovery%20approach.%20Expert%20Opin%20Drug%20Discov%2017(6):641%E2%80%93659" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<cite>Ma J, Konings M, Verbon A, van de Sande WWJ (2023) A <em>Falciformispora senegalensis</em> grain model in Galleria mellonella larvae. Med Mycol. 10.1093/mmy/myad070
</cite> [<a href="https://doi.org/10.1093/mmy/myad070" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10436144/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37451815/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20J,%20Konings%20M,%20Verbon%20A,%20van%20de%20Sande%20WWJ%20(2023)%20A%20Falciformispora%20senegalensis%20grain%20model%20in%20Galleria%20mellonella%20larvae.%20Med%20Mycol.%2010.1093/mmy/myad070" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<cite>Ma J, Eadie K, Schippers M, Fahal A, Laleu B, Verbon A, van de Sande WWJ (2024) Novel compound MMV1804559 from the global health priority box exhibits in vitro and in vivo activity against <em>Madurella mycetomatis</em>. Int J Mol Sci 25(11):6227. 10.3390/ijms25116227
</cite> [<a href="https://doi.org/10.3390/ijms25116227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11172423/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38892422/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20J,%20Eadie%20K,%20Schippers%20M,%20Fahal%20A,%20Laleu%20B,%20Verbon%20A,%20van%20de%20Sande%20WWJ%20(2024)%20Novel%20compound%20MMV1804559%20from%20the%20global%20health%20priority%20box%20exhibits%20in%20vitro%20and%20in%20vivo%20activity%20against%20Madurella%20mycetomatis.%20Int%20J%20Mol%20Sci%2025(11):6227.%2010.3390/ijms25116227" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<cite>Ma J, Eadie K, Konings M, Fahal A, Verbon A, Van de Sande WJ (2025) Ibrexafungerp prolongs survival and reduces theeumycetoma grain size in Galleria mellonella infection models of two different causative agents of eumycetoma. J Antimicrob Chemother 80(6):1733–1741. 10.1093/jac/dkaf133
</cite> [<a href="https://doi.org/10.1093/jac/dkaf133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12129584/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40304084/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma%20J,%20Eadie%20K,%20Konings%20M,%20Fahal%20A,%20Verbon%20A,%20Van%20de%20Sande%20WJ%20(2025)%20Ibrexafungerp%20prolongs%20survival%20and%20reduces%20theeumycetoma%20grain%20size%20in%20Galleria%20mellonella%20infection%20models%20of%20two%20different%20causative%20agents%20of%20eumycetoma.%20J%20Antimicrob%20Chemother%2080(6):1733%E2%80%931741.%2010.1093/jac/dkaf133" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<cite>Nakano M, Aoki Y, Yamaguchi H (2019) [Drug properties of fosravuconazole L-lysine ethanolate (NAILIN(®) capsules 100 mg), a new oral azole therapeutic for onychomycosis: an analysis based on non-clinical and clinical trial data]. Nihon Yakurigaku Zasshi 153(2):79–87
</cite> [<a href="https://doi.org/10.1254/fpj.153.79" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30745518/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nakano%20M,%20Aoki%20Y,%20Yamaguchi%20H%20(2019)%20%5BDrug%20properties%20of%20fosravuconazole%20L-lysine%20ethanolate%20(NAILIN(%C2%AE)%20capsules%20100%E2%80%85mg),%20a%20new%20oral%20azole%20therapeutic%20for%20onychomycosis:%20an%20analysis%20based%20on%20non-clinical%20and%20clinical%20trial%20data%5D.%20Nihon%20Yakurigaku%20Zasshi%20153(2):79%E2%80%9387" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<cite>N’Diaye B, Dieng MT, Perez A, Stockmeyer M, Bakshi R (2006) Clinical efficacy and safety of oral terbinafine in fungal mycetoma. Int J Dermatol 45(2):154–157
</cite> [<a href="https://doi.org/10.1111/j.1365-4632.2004.02392.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16445509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?N%E2%80%99Diaye%20B,%20Dieng%20MT,%20Perez%20A,%20Stockmeyer%20M,%20Bakshi%20R%20(2006)%20Clinical%20efficacy%20and%20safety%20of%20oral%20terbinafine%20in%20fungal%20mycetoma.%20Int%20J%20Dermatol%2045(2):154%E2%80%93157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<cite>Negroni R, Tobón A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A (2005) Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 47(6):339–346
</cite> [<a href="https://doi.org/10.1590/s0036-46652005000600006" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16553324/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Negroni%20R,%20Tob%C3%B3n%20A,%20Bustamante%20B,%20Shikanai-Yasuda%20MA,%20Patino%20H,%20Restrepo%20A%20(2005)%20Posaconazole%20treatment%20of%20refractory%20eumycetoma%20and%20chromoblastomycosis.%20Rev%20Inst%20Med%20Trop%20Sao%20Paulo%2047(6):339%E2%80%93346" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<cite>Nenoff P, van de Sande WW, Fahal AH, Reinel D, Schöfer H (2015) Eumycetoma and actinomycetoma–an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy. J Eur Acad Dermatol Venereol 29(10):1873–1883
</cite> [<a href="https://doi.org/10.1111/jdv.13008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25726758/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nenoff%20P,%20van%20de%20Sande%20WW,%20Fahal%20AH,%20Reinel%20D,%20Sch%C3%B6fer%20H%20(2015)%20Eumycetoma%20and%20actinomycetoma%E2%80%93an%20update%20on%20causative%20agents,%20epidemiology,%20pathogenesis,%20diagnostics%20and%20therapy.%20J%20Eur%20Acad%20Dermatol%20Venereol%2029(10):1873%E2%80%931883" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<cite>Nyuykonge B, Siddig E, Mhmoud NA, Bakhiet S, Zijlstra E, Verbon A, Fahal AH, van de Sande WWJ (2023) Wako β-D-glucan assay can be used to measure serum β-D-glucan in Sudanese patients to aid with diagnosis of eumycetoma caused by <em>Madurella mycetomatis</em>. J Eur Acad Dermatol Venereol 37(4):783–786
</cite> [<a href="https://doi.org/10.1111/jdv.18642" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36201367/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nyuykonge%20B,%20Siddig%20E,%20Mhmoud%20NA,%20Bakhiet%20S,%20Zijlstra%20E,%20Verbon%20A,%20Fahal%20AH,%20van%20de%20Sande%20WWJ%20(2023)%20Wako%20%CE%B2-D-glucan%20assay%20can%20be%20used%20to%20measure%20serum%20%CE%B2-D-glucan%20in%20Sudanese%20patients%20to%20aid%20with%20diagnosis%20of%20eumycetoma%20caused%20by%20Madurella%20mycetomatis.%20J%20Eur%20Acad%20Dermatol%20Venereol%2037(4):783%E2%80%93786" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<cite>Nyuykonge B, Siddig EE, Nyaoke BA, Zijlstra EE, Verbon A, Bakhiet SM, Fahal AH, van de Sande WWJ (2024) Using (1,3)-β-D-glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by <em>Madurella mycetomatis</em>. Mycoses 67(1):e13664
</cite> [<a href="https://doi.org/10.1111/myc.13664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37872649/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Nyuykonge%20B,%20Siddig%20EE,%20Nyaoke%20BA,%20Zijlstra%20EE,%20Verbon%20A,%20Bakhiet%20SM,%20Fahal%20AH,%20van%20de%20Sande%20WWJ%20(2024)%20Using%20(1,3)-%CE%B2-D-glucan%20concentrations%20in%20serum%20to%20monitor%20the%20response%20of%20azole%20therapy%20in%20patients%20with%20eumycetoma%20caused%20by%20Madurella%20mycetomatis.%20Mycoses%2067(1):e13664" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<cite>Ryder NS (1992) Terbinafine: mode of action and properties of the squalene epoxidase inhibition. Br J Dermatol 126(Suppl 39):2–7
</cite> [<a href="https://doi.org/10.1111/j.1365-2133.1992.tb00001.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1543672/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ryder%20NS%20(1992)%20Terbinafine:%20mode%20of%20action%20and%20properties%20of%20the%20squalene%20epoxidase%20inhibition.%20Br%20J%20Dermatol%20126(Suppl%2039):2%E2%80%937" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<cite>Sheehan G, Konings M, Lim W, Fahal A, Kavanagh K, van de Sande WWJ (2020) Proteomic analysis of the processes leading to <em>Madurella mycetomatis</em> grain formation in <em>Galleria mellonella</em> larvae. PLoS Negl Trop Dis 14(4):e0008190
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0008190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7141616/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32267851/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sheehan%20G,%20Konings%20M,%20Lim%20W,%20Fahal%20A,%20Kavanagh%20K,%20van%20de%20Sande%20WWJ%20(2020)%20Proteomic%20analysis%20of%20the%20processes%20leading%20to%20Madurella%20mycetomatis%20grain%20formation%20in%20Galleria%20mellonella%20larvae.%20PLoS%20Negl%20Trop%20Dis%2014(4):e0008190" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<cite>Siddig EE, Nyuykonge B, Mhmoud NA, Abdallah OB, Bahar MEN, Ahmed ES, Nyaoke B, Zijlstra EE, Verbon A, Bakhiet SM, Fahal AH, van de Sande WWJ (2023) Comparing the performance of the common used eumycetoma diagnostic tests. Mycoses 66(5):420–429
</cite> [<a href="https://doi.org/10.1111/myc.13561" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36583225/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Siddig%20EE,%20Nyuykonge%20B,%20Mhmoud%20NA,%20Abdallah%20OB,%20Bahar%20MEN,%20Ahmed%20ES,%20Nyaoke%20B,%20Zijlstra%20EE,%20Verbon%20A,%20Bakhiet%20SM,%20Fahal%20AH,%20van%20de%20Sande%20WWJ%20(2023)%20Comparing%20the%20performance%20of%20the%20common%20used%20eumycetoma%20diagnostic%20tests.%20Mycoses%2066(5):420%E2%80%93429" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<cite>Singh G, Agarwal R, Khullar S, Xess I, Sharma VK, Goyal A (2020) Recalcitrant eumycetoma of the foot: Financial burden a major barrier on the road of recovery. PLoS Negl Trop Dis 14(8):e0008356
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0008356" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7410166/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32760057/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Singh%20G,%20Agarwal%20R,%20Khullar%20S,%20Xess%20I,%20Sharma%20VK,%20Goyal%20A%20(2020)%20Recalcitrant%20eumycetoma%20of%20the%20foot:%20Financial%20burden%20a%20major%20barrier%20on%20the%20road%20of%20recovery.%20PLoS%20Negl%20Trop%20Dis%2014(8):e0008356" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<cite>Sow D, Ndiaye M, Sarr L, Kanté MD, Ly F, Dioussé P, Faye BT, Gaye AM, Sokhna C, Ranque S, Faye B (2020) Mycetoma epidemiology, diagnosis management, and outcome in three hospital centres in Senegal from 2008 to 2018. PLoS One 15(4):e0231871
</cite> [<a href="https://doi.org/10.1371/journal.pone.0231871" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7182189/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32330155/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sow%20D,%20Ndiaye%20M,%20Sarr%20L,%20Kant%C3%A9%20MD,%20Ly%20F,%20Diouss%C3%A9%20P,%20Faye%20BT,%20Gaye%20AM,%20Sokhna%20C,%20Ranque%20S,%20Faye%20B%20(2020)%20Mycetoma%20epidemiology,%20diagnosis%20management,%20and%20outcome%20in%20three%20hospital%20centres%20in%20Senegal%20from%202008%20to%202018.%20PLoS%20One%2015(4):e0231871" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<cite>Tissot F, Lamoth F, Hauser PM, Orasch C, Flückiger U, Siegemund M, Zimmerli S, Calandra T, Bille J, Eggimann P, Marchetti O, Fungal Infection Network of S (2013) β-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med 188(9):1100–1109
</cite> [<a href="https://doi.org/10.1164/rccm.201211-2069OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23782027/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tissot%20F,%20Lamoth%20F,%20Hauser%20PM,%20Orasch%20C,%20Fl%C3%BCckiger%20U,%20Siegemund%20M,%20Zimmerli%20S,%20Calandra%20T,%20Bille%20J,%20Eggimann%20P,%20Marchetti%20O,%20Fungal%20Infection%20Network%20of%20S%20(2013)%20%CE%B2-glucan%20antigenemia%20anticipates%20diagnosis%20of%20blood%20culture-negative%20intraabdominal%20candidiasis.%20Am%20J%20Respir%20Crit%20Care%20Med%20188(9):1100%E2%80%931109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51"><cite> Todd M (2025) Benzoxazoles manuscript writing #5. PUblisher. <a href="https://github.com/OpenSourceMycetoma/series-5-benzimidazoles/issues/5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/OpenSourceMycetoma/series-5-benzimidazoles/issues/5</a>. Accessed 26 Mar 2025</cite></li>
<li id="CR52">
<cite>van Belkum A, Fahal AH, van de Sande WW (2011) In vitro susceptibility of <em>Madurella mycetomatis</em> to posaconazole and terbinafine. Antimicrob Agents Chemother 55(4):1771–1773
</cite> [<a href="https://doi.org/10.1128/AAC.01045-10" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3067195/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21263050/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20Belkum%20A,%20Fahal%20AH,%20van%20de%20Sande%20WW%20(2011)%20In%20vitro%20susceptibility%20of%20Madurella%20mycetomatis%20to%20posaconazole%20and%20terbinafine.%20Antimicrob%20Agents%20Chemother%2055(4):1771%E2%80%931773" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<cite>van de Sande WWJ (2021) In vitro susceptibility testing for black grain eumycetoma causative agents. Trans R Soc Trop Med Hyg 115(4):343–354
</cite> [<a href="https://doi.org/10.1093/trstmh/traa184" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8046409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33537781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20de%20Sande%20WWJ%20(2021)%20In%20vitro%20susceptibility%20testing%20for%20black%20grain%20eumycetoma%20causative%20agents.%20Trans%20R%20Soc%20Trop%20Med%20Hyg%20115(4):343%E2%80%93354" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<cite>van de Sande WWJ, Fahal AH (2024) An updated list of eumycetoma causative agents and their differences in grain formation and treatment response. Clin Microbiol Rev 37(2):e0003423
</cite> [<a href="https://doi.org/10.1128/cmr.00034-23" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11237709/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38690871/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20de%20Sande%20WWJ,%20Fahal%20AH%20(2024)%20An%20updated%20list%20of%20eumycetoma%20causative%20agents%20and%20their%20differences%20in%20grain%20formation%20and%20treatment%20response.%20Clin%20Microbiol%20Rev%2037(2):e0003423" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<cite>van de Sande WW, de Kat J, Coppens J, Ahmed AO, Fahal A, Verbrugh H, van Belkum A (2007) Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. Microbes Infect 9(9):1114–1123
</cite> [<a href="https://doi.org/10.1016/j.micinf.2007.05.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17644456/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20de%20Sande%20WW,%20de%20Kat%20J,%20Coppens%20J,%20Ahmed%20AO,%20Fahal%20A,%20Verbrugh%20H,%20van%20Belkum%20A%20(2007)%20Melanin%20biosynthesis%20in%20Madurella%20mycetomatis%20and%20its%20effect%20on%20susceptibility%20to%20itraconazole%20and%20ketoconazole.%20Microbes%20Infect%209(9):1114%E2%80%931123" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<cite>van de Sande WW, el Maghoub S, Fahal AH, Goodfellow M, Welsh O, Zijlstra E (2014) The mycetoma knowledge gap: identification of research priorities. PLoS Negl Trop Dis 8(3):e2667
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0002667" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3967943/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24675533/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?van%20de%20Sande%20WW,%20el%20Maghoub%20S,%20Fahal%20AH,%20Goodfellow%20M,%20Welsh%20O,%20Zijlstra%20E%20(2014)%20The%20mycetoma%20knowledge%20gap:%20identification%20of%20research%20priorities.%20PLoS%20Negl%20Trop%20Dis%208(3):e2667" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<cite> van de Sande W, Fahal A, Ahmed SA, Serrano JA, Bonifaz A, Zijlstra E, eumycetoma working g (2018) Closing the mycetoma knowledge gap. Med Mycol 56(suppl_1):153–164</cite> [<a href="https://doi.org/10.1093/mmy/myx061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28992217/" class="usa-link">PubMed</a>]</li>
<li id="CR58">
<cite>Wadal A, Elhassan TA, Zein HA, Abdel-Rahman ME, Fahal AH (2016) Predictors of post-operative mycetoma recurrence using machine-learning algorithms: the mycetoma research center experience. PLoS Negl Trop Dis 10(10):e0005007
</cite> [<a href="https://doi.org/10.1371/journal.pntd.0005007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5087941/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27798643/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wadal%20A,%20Elhassan%20TA,%20Zein%20HA,%20Abdel-Rahman%20ME,%20Fahal%20AH%20(2016)%20Predictors%20of%20post-operative%20mycetoma%20recurrence%20using%20machine-learning%20algorithms:%20the%20mycetoma%20research%20center%20experience.%20PLoS%20Negl%20Trop%20Dis%2010(10):e0005007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<cite>Watanabe NA, Miyazaki M, Horii T, Sagane K, Tsukahara K, Hata K (2012) E1210, a new broad-spectrum antifungal, suppresses <em>Candida albicans</em> hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis. Antimicrob Agents Chemother 56(2):960–971
</cite> [<a href="https://doi.org/10.1128/AAC.00731-11" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3264227/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22143530/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Watanabe%20NA,%20Miyazaki%20M,%20Horii%20T,%20Sagane%20K,%20Tsukahara%20K,%20Hata%20K%20(2012)%20E1210,%20a%20new%20broad-spectrum%20antifungal,%20suppresses%20Candida%20albicans%20hyphal%20growth%20through%20inhibition%20of%20glycosylphosphatidylinositol%20biosynthesis.%20Antimicrob%20Agents%20Chemother%2056(2):960%E2%80%93971" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<cite>Welsh O, Vera-Cabrera L, Salinas-Carmona MC (2013) Current treatment for <em>Nocardia</em> infections. Expert Opin Pharmacother 14(17):2387–2398
</cite> [<a href="https://doi.org/10.1517/14656566.2013.842553" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24093436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Welsh%20O,%20Vera-Cabrera%20L,%20Salinas-Carmona%20MC%20(2013)%20Current%20treatment%20for%20Nocardia%20infections.%20Expert%20Opin%20Pharmacother%2014(17):2387%E2%80%932398" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61"><cite>WHO (2016) Assessing the burden of mycetoma. WHO Geneva (WHA69.21). <a href="https://iris.who.int/handle/10665/252801" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://iris.who.int/handle/10665/252801</a></cite></li>
<li id="CR62">
<cite>Zein HA, Fahal AH, el Mahgoub S, El Hassan TA, Abdel-Rahman ME (2012) Predictors of cure, amputation and follow-up dropout among patients with mycetoma seen at the Mycetoma Research Centre, University of Khartoum, Sudan. Trans R Soc Trop Med Hyg 106(11):639–644
</cite> [<a href="https://doi.org/10.1016/j.trstmh.2012.07.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22854685/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zein%20HA,%20Fahal%20AH,%20el%20Mahgoub%20S,%20El%20Hassan%20TA,%20Abdel-Rahman%20ME%20(2012)%20Predictors%20of%20cure,%20amputation%20and%20follow-up%20dropout%20among%20patients%20with%20mycetoma%20seen%20at%20the%20Mycetoma%20Research%20Centre,%20University%20of%20Khartoum,%20Sudan.%20Trans%20R%20Soc%20Trop%20Med%20Hyg%20106(11):639%E2%80%93644" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR63">
<cite>Zhang J, Li L, Lv Q, Yan L, Wang Y, Jiang Y (2019) The fungal CYP51s: their functions, structures, related drug resistance, and inhibitors. Front Microbiol 10:691
</cite> [<a href="https://doi.org/10.3389/fmicb.2019.00691" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6491756/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31068906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhang%20J,%20Li%20L,%20Lv%20Q,%20Yan%20L,%20Wang%20Y,%20Jiang%20Y%20(2019)%20The%20fungal%20CYP51s:%20their%20functions,%20structures,%20related%20drug%20resistance,%20and%20inhibitors.%20Front%20Microbiol%2010:691" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR64">
<cite>Zijlstra EE, van de Sande WWJ, Welsh O, Mahgoub ES, Goodfellow M, Fahal AH (2016) Mycetoma: a unique neglected tropical disease. Lancet Infect Dis 16(1):100–112
</cite> [<a href="https://doi.org/10.1016/S1473-3099(15)00359-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26738840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zijlstra%20EE,%20van%20de%20Sande%20WWJ,%20Welsh%20O,%20Mahgoub%20ES,%20Goodfellow%20M,%20Fahal%20AH%20(2016)%20Mycetoma:%20a%20unique%20neglected%20tropical%20disease.%20Lancet%20Infect%20Dis%2016(1):100%E2%80%93112" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR65">
<cite>Zonios DI, Bennett JE (2008) Update on azole antifungals. Semin Respir Crit Care Med 29(2):198–210
</cite> [<a href="https://doi.org/10.1055/s-2008-1063858" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18366001/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zonios%20DI,%20Bennett%20JE%20(2008)%20Update%20on%20azole%20antifungals.%20Semin%20Respir%20Crit%20Care%20Med%2029(2):198%E2%80%93210" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ol></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>No datasets were generated or analysed during the current study.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Applied Microbiology and Biotechnology are provided here courtesy of <strong>Springer</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1007/s00253-025-13580-5"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/253_2025_Article_13580.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.1 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12364754/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12364754/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12364754%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12364754/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12364754/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12364754/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40830304/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12364754/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40830304/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12364754/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12364754/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="aZmchXnJ1d7CT8VuD9jRrRkUnIA3aCBIVSqb6cnNHmszrWcwWLSQVuzq0ljEOuhL">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
